LNP biotech looks to go be­yond the liv­er, rais­ing $25M in seed mon­ey to move for­ward

Hopewell Ther­a­peu­tics an­nounced $25 mil­lion in seed fund­ing on Wednes­day, with the Boston-area biotech look­ing to make the next break­through in de­liv­er­ing med­i­cines be­yond the liv­er.

The seed round was backed by a num­ber of ven­ture cap­i­tal firms, in­clud­ing 5Y Cap­i­tal and Mass Ave Cap­i­tal, and will be used to ex­pand Hopewell’s in­ter­nal lab ca­pa­bil­i­ties and grow its lipid nanopar­ti­cle li­brary, ac­cord­ing to CEO Louis Bren­ner. The com­pa­ny’s al­so look­ing for ex­ter­nal part­ner­ships with com­pa­nies fo­cused on can­cer.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER